+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 40Years - 85Years
All Genders
ID07514858

Randomized, Double-Blind Study of Oral Lu AF28996 Versus Placebo in Adults with Parkinsons Disease Experiencing Motor Fluctuations

Led by H. Lundbeck A/S · Updated on 2026-09-08

150

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of Lu AF28996 in adults aged 40 to 85 with Parkinsons disease PD who experience motor fluctuations despite optimized medications. These motor fluctuations include periods when PD medications do not fully control symptoms like slowness, stiffness, and tremor, and some participants may have involuntary movements called dyskinesia. The study aims to determine if adding Lu AF28996 to current PD treatments can increase the time participants spend with well-controlled movement symptoms without troublesome dyskinesia. Participants will be randomly assigned to receive either Lu AF28996 or a matching placebo as an add-on to their existing PD medications for up to 23 weeks. Both treatments are taken orally according to a flexible dosing schedule. The study is double-blind, meaning neither participants nor researchers know who receives the active drug or placebo during the trial period. Throughout the study, participants will keep diaries to record their daily motor symptoms, including good ON time when symptoms are well-controlled, OFF time, and dyskinesia. Various assessments will measure changes in motor function, dyskinesia severity, sleep quality, and quality of life at baseline and Week 19. Blood samples will be collected to monitor drug levels. Safety and tolerability will be closely monitored, and the total participation duration is approximately 23 weeks.

CONDITIONS

Brief Title

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

Research Team

E

Email contact via H. Lundbeck A/S

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here